Feb 16, 2017

Here's what Seema Verma told the Senate Finance Committee

Seema Verma, President Trump's nominee to lead the Centers for Medicare and Medicaid Services, is testifying before the Senate Finance Committee at her confirmation hearing this morning. So far, she has dodged a question about the new Obamacare rule, but made it clear she wants more flexibility in the benefits health insurers have to cover. She also suggested she'll be an ally for pharmacy benefit managers, the middlemen who are increasingly getting blamed for having a role in rising drug prices.

Read on for the highlights of what she said.

  • Said she couldn't comment on the new Obamacare regulation CMS released yesterday to tighten the enrollment rules: "I have not been involved in the development of that rule."
  • Democrats said the rule goes against President Trump's commitment to everyone having coverage, to which Verma replied with the standard GOP line: "The president and I both agree we need...to fight for coverage and make sure all Americans have access to affordable, high-quality health care."
  • She doesn't support turning Medicare into a "voucher program," as described by Sen. Bill Nelson (meaning GOP proposals to give private plans a bigger role). "I'm not supportive of that, but I think it's important we look for ways of making sure the program is sustainable for the future."
  • She supports changing Medicaid to make it work better, "whether that's a block grant or a per capita cap."
  • When asked whether Medicare should negotiate drug prices, she gave a shout-out to the increasingly villainized pharmacy benefit managers. "I think we need to do everything we can do to make drugs more affordable for seniors. I'm thankful we have the PBMs and Part D program."
  • On Obamacare's essential health benefits: "What works for one person might not work for another person." For example, some women might not want maternity coverage, she said. "I think it's important people be able to make the decisions that work best for them and their families."
  • Unsurprisingly, she praised Indiana's Medicaid system that she helped design, which uses health savings accounts in Medicaid. "What we find is just because individuals are poor doesn't mean they're not capable of making decisions."
  • She'll be recusing herself of any possible conflicts of interest. The AP reports she's promised to sell her consulting firm, which worked on the design of Indiana's Medicaid reform plan, within 90 days of being confirmed.
  • Called the 2015 MACRA bill, which reformed how Medicare pays doctors, an "important step forward" for outcomes and providers.

Go deeper

Coronavirus spreads to new countries, while U.S. confirms 57 cases

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens.

Public health officials confirmed Tuesday the U.S. has 57 people with the novel coronavirus, mostly those repatriated from the Diamond Princess cruise ship — an increase they had expected after the passengers were allowed to return home from Japan against their initial advice.

The big picture: COVID-19 has killed more than 2,700 people and infected more than 80,000 others, mostly in mainland China. There's only been two cases of person-to-person infections in the U.S. so far, but the Centers for Disease Control and Prevention is now warning that Americans should prepare for a much broader outbreak here.

Go deeperArrowUpdated 1 hour ago - Health

Space tourism gets ready for launch

Illustration: Sarah Grillo/Axios

Multiple space tourism companies are aiming to send their first customers to the edge of space before the end of this year.

Why it matters: Right now, most revenue in the space industry is tied up in government contracts, but experts say the maturing industry will need tourism to grow into the $1 trillion economy some predict it could be.

Go deeperArrow2 hours ago - Science